CRBU
Price
$1.86
Change
+$0.10 (+5.68%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
165.91M
103 days until earnings call
Intraday BUY SELL Signals
PYXS
Price
$4.61
Change
+$0.70 (+17.90%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
273.34M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs PYXS

Header iconCRBU vs PYXS Comparison
Open Charts CRBU vs PYXSBanner chart's image
Caribou Biosciences
Price$1.86
Change+$0.10 (+5.68%)
Volume$8.97K
Capitalization165.91M
Pyxis Oncology
Price$4.61
Change+$0.70 (+17.90%)
Volume$28.24K
Capitalization273.34M
CRBU vs PYXS Comparison Chart in %
CRBU
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBU vs. PYXS commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and PYXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CRBU: $1.76 vs. PYXS: $3.92)
Brand notoriety: CRBU and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 21% vs. PYXS: 130%
Market capitalization -- CRBU: $165.91M vs. PYXS: $273.34M
CRBU [@Biotechnology] is valued at $165.91M. PYXS’s [@Biotechnology] market capitalization is $273.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRBU and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 4 bearish.
  • PYXS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CRBU and PYXS are a good buy in the short-term.

Price Growth

CRBU (@Biotechnology) experienced а -5.88% price change this week, while PYXS (@Biotechnology) price change was -26.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

PYXS is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($273M) has a higher market cap than CRBU($166M). PYXS YTD gains are higher at: 151.282 vs. CRBU (10.692). PYXS has higher annual earnings (EBITDA): -83.16M vs. CRBU (-150.76M). CRBU has more cash in the bank: 184M vs. PYXS (88.9M). PYXS has less debt than CRBU: PYXS (19.5M) vs CRBU (25.9M). CRBU has higher revenues than PYXS: CRBU (9.12M) vs PYXS (2.82M).
CRBUPYXSCRBU / PYXS
Capitalization166M273M61%
EBITDA-150.76M-83.16M181%
Gain YTD10.692151.2827%
P/E RatioN/AN/A-
Revenue9.12M2.82M323%
Total Cash184M88.9M207%
Total Debt25.9M19.5M133%
TECHNICAL ANALYSIS
Technical Analysis
CRBUPYXS
RSI
ODDS (%)
Bullish Trend 6 days ago
81%
Bearish Trend 6 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
83%
Bearish Trend 6 days ago
83%
Momentum
ODDS (%)
Bearish Trend 6 days ago
87%
Bullish Trend 6 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 6 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 6 days ago
89%
Aroon
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXINF23.79N/A
N/A
Oxford Instruments plc
PRSEF4.95N/A
N/A
Prosafe SE (Cyprus)
SCCFF0.21N/A
N/A
Strategic Resources Inc.
VOLAF28.50N/A
N/A
Volvo AB
WILYY15.80N/A
N/A
Demant AS

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-0.56%
CRSP - CRBU
59%
Loosely correlated
-1.13%
RXRX - CRBU
53%
Loosely correlated
-0.69%
BEAM - CRBU
52%
Loosely correlated
-2.83%
MGNX - CRBU
51%
Loosely correlated
-2.06%
AXON - CRBU
50%
Loosely correlated
+0.91%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-10.71%
BEAM - PYXS
50%
Loosely correlated
-2.83%
SYRE - PYXS
46%
Loosely correlated
-0.91%
BDTX - PYXS
43%
Loosely correlated
-8.49%
CRBU - PYXS
42%
Loosely correlated
-0.56%
ZBIO - PYXS
42%
Loosely correlated
-7.07%
More